Love claims EU data exclusivity push jeopardises world generics supply
This article was originally published in Scrip
Another voice in support of India's role as the affordable pharmacy of the developing world was heard on 23 March as James Love, director of the Washington-based Knowledge Ecology International, writing in the British Medical Journal, called for the European Union to eliminate "demands that India adopt exclusive rights on drug test data, or lower its standards for granting patents on medical inventions."
You may also be interested in...
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.
Deal news from Strides Pharma, Pharmaceutics Intl., Cipla, Wanbury, AstraZeneca, Syntekabio, Arctoris, Mundipharma, Samsung Bioepis…